Silvan Licher

3.9k total citations · 1 hit paper
41 papers, 1.6k citations indexed

About

Silvan Licher is a scholar working on Psychiatry and Mental health, Physiology and Economics and Econometrics. According to data from OpenAlex, Silvan Licher has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 9 papers in Physiology and 8 papers in Economics and Econometrics. Recurrent topics in Silvan Licher's work include Dementia and Cognitive Impairment Research (20 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Alzheimer's disease research and treatments (7 papers). Silvan Licher is often cited by papers focused on Dementia and Cognitive Impairment Research (20 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Alzheimer's disease research and treatments (7 papers). Silvan Licher collaborates with scholars based in Netherlands, United States and United Kingdom. Silvan Licher's co-authors include M. Arfan Ikram, M. Kamran Ikram, Frank J. Wolters, Maarten J.G. Leening, Peter J. Koudstaal, Albert Hofman, Ünal Mutlu, Lana Fani, Blossom C. M. Stephan and Trudy Voortman and has published in prestigious journals such as Nature Medicine, American Journal of Psychiatry and Brain.

In The Last Decade

Silvan Licher

38 papers receiving 1.6k citations

Hit Papers

Plasma tau, neurofilament light chain and amyloid-β level... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvan Licher Netherlands 21 579 408 217 176 150 41 1.6k
Seong Yoon Kim South Korea 24 762 1.3× 394 1.0× 171 0.8× 112 0.6× 114 0.8× 81 1.7k
Elżbieta Kuźma United Kingdom 15 451 0.8× 299 0.7× 236 1.1× 204 1.2× 65 0.4× 32 1.4k
Marcel Olde‐Rikkert Netherlands 16 368 0.6× 286 0.7× 166 0.8× 126 0.7× 129 0.9× 28 1.2k
Rod Walker United States 26 543 0.9× 519 1.3× 393 1.8× 406 2.3× 84 0.6× 90 2.9k
Elizabeth A. McAninch United States 27 447 0.8× 605 1.5× 154 0.7× 207 1.2× 62 0.4× 60 2.7k
Ilianna Lourida United Kingdom 16 503 0.9× 493 1.2× 465 2.1× 166 0.9× 49 0.3× 34 1.7k
Hua Jin China 14 622 1.1× 316 0.8× 94 0.4× 166 0.9× 132 0.9× 43 1.5k
Shahram Oveisgharan United States 21 366 0.6× 328 0.8× 252 1.2× 386 2.2× 82 0.5× 113 1.8k
Ramit Ravona‐Springer Israel 20 468 0.8× 473 1.2× 182 0.8× 105 0.6× 61 0.4× 94 1.4k
Jules J. Claus Netherlands 19 1.1k 1.8× 654 1.6× 185 0.9× 135 0.8× 110 0.7× 49 2.2k

Countries citing papers authored by Silvan Licher

Since Specialization
Citations

This map shows the geographic impact of Silvan Licher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvan Licher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvan Licher more than expected).

Fields of papers citing papers by Silvan Licher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvan Licher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvan Licher. The network helps show where Silvan Licher may publish in the future.

Co-authorship network of co-authors of Silvan Licher

This figure shows the co-authorship network connecting the top 25 collaborators of Silvan Licher. A scholar is included among the top collaborators of Silvan Licher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvan Licher. Silvan Licher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Licher, Silvan, et al.. (2025). Temporal Trends of Anticholinergic Drug Exposure Among Older Adults: A 25-Year Population-Based Study. Drug Safety. 48(10). 1141–1147.
2.
Mooldijk, Sanne S., et al.. (2025). Time to nursing home admission and death in people with dementia: systematic review and meta-analysis. BMJ. 388. e080636–e080636. 7 indexed citations
3.
Kieboom, Brenda C.T., et al.. (2024). Healthcare avoidance during the early stages of the COVID-19 pandemic and all-cause mortality: a longitudinal community-based study. British Journal of General Practice. 74(748). e791–e796.
5.
Schepper, Evelien de, D. Schiphof, W.E. van Spil, et al.. (2023). Changes to consultations and diagnosis of osteoarthritis in primary care during the COVID-19 pandemic. Osteoarthritis and Cartilage. 31(6). 829–838. 2 indexed citations
6.
Ikram, Muhammad, et al.. (2023). Patient perspectives on telemedicine during the COVID-19 pandemic: a mixed-methods community-based study. BMC Health Services Research. 23(1). 803–803. 9 indexed citations
7.
Luik, Annemarie I., Guy Brusselle, Patrick Bindels, et al.. (2022). Sex-specific patterns and lifetime risk of multimorbidity in the general population: a 23-year prospective cohort study. BMC Medicine. 20(1). 304–304. 11 indexed citations
8.
Licher, Silvan, Frank J. Wolters, Jelena Pavlović, et al.. (2022). Effects of Eligibility Criteria on Patient Selection and Treatment Implications from 10 Multidomain Dementia Prevention Trials: A Population-Based Study. Neuroepidemiology. 57(1). 14–24. 2 indexed citations
9.
Ikram, M. Kamran, Brenda C.T. Kieboom, Robin P. Peeters, et al.. (2021). Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study. PLoS Medicine. 18(11). e1003854–e1003854. 81 indexed citations
10.
Mooldijk, Sanne S., Amber Yaqub, Frank J. Wolters, et al.. (2021). Life expectancy with and without dementia in persons with mild cognitive impairment in the community. Journal of the American Geriatrics Society. 70(2). 481–489. 20 indexed citations
11.
Vinke, Elisabeth J., Pınar Yilmaz, Florian Dubost, et al.. (2021). Intracranial arteriosclerosis is related to cerebral small vessel disease: a prospective cohort study. Neurobiology of Aging. 105. 16–24. 11 indexed citations
12.
Licher, Silvan, Natalie Terzikhan, Frank J.A. van Rooij, et al.. (2021). Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease. European Journal of Epidemiology. 36(6). 649–654. 8 indexed citations
13.
Willik, Kimberly D. van der, Silvan Licher, Elisabeth J. Vinke, et al.. (2020). Trajectories of Cognitive and Motor Function Between Ages 45 and 90 Years: A Population-Based Study. The Journals of Gerontology Series A. 76(2). 297–306. 32 indexed citations
14.
Ma, Yuan, Frank J. Wolters, Lori B. Chibnik, et al.. (2019). Variation in blood pressure and long-term risk of dementia: A population-based cohort study. PLoS Medicine. 16(11). e1002933–e1002933. 59 indexed citations
15.
Darweesh, Sirwan K.L., Silvan Licher, Frank J. Wolters, et al.. (2019). Quantitative gait, cognitive decline, and incident dementia: The Rotterdam Study. Alzheimer s & Dementia. 15(10). 1264–1273. 34 indexed citations
16.
Licher, Silvan, Alis Heshmatollah, Kimberly D. van der Willik, et al.. (2019). Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study. PLoS Medicine. 16(2). e1002741–e1002741. 81 indexed citations
17.
Licher, Silvan, Shahzad Ahmad, Hata Karamujić‐Čomić, et al.. (2019). Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population. Nature Medicine. 25(9). 1364–1369. 146 indexed citations
18.
Licher, Silvan, Sirwan K.L. Darweesh, Frank J. Wolters, et al.. (2018). Lifetime risk of common neurological diseases in the elderly population. Journal of Neurology Neurosurgery & Psychiatry. 90(2). 148–156. 55 indexed citations
19.
Licher, Silvan, Pınar Yilmaz, Maarten J.G. Leening, et al.. (2018). External validation of four dementia prediction models for use in the general community-dwelling population: a comparative analysis from the Rotterdam Study. European Journal of Epidemiology. 33(7). 645–655. 74 indexed citations
20.
Licher, Silvan, Renée F.A.G. de Bruijn, Frank J. Wolters, et al.. (2017). Vitamin D and the Risk of Dementia: The Rotterdam Study. Journal of Alzheimer s Disease. 60(3). 989–997. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026